Welcome to your daily briefing on healthcare developments in Indiana. Today we're covering 5 key stories including updates on indiana healthcare headlines, indiana healthcare updates, background & context. Let's dive in.
2 stories
The Indiana Health Information Exchange operates a data network developed by the Regenstrief Institute to improve health and healthcare through information exchange across Indiana.
For Indiana healthcare professionals, IHIE enables more coordinated, data-driven patient care by facilitating seamless health information sharing throughout the state.
A comprehensive guide outlines the legal, administrative, and procedural requirements for establishing hospitals, emphasizing standards of care and patient safety.
IN healthcare professionals operating or planning facilities can benchmark these rigorous licensing frameworks to strengthen their own compliance and quality assurance programs.
Reach healthcare professionals
0 stories
3 stories
A vendor is a business associate if they create, receive, maintain, or transmit PHI on behalf of the covered entity. They are NOT a business associate just because they happen to be in a building with PHI or could conceivably access it. The functional test matters, not the proximity test.
Forcing BAA execution on vendors who do not meet the functional test creates contractual bloat and weakens the negotiating position with vendors who actually do. Failing to execute BAAs with true business associates exposes the covered entity to OCR enforcement.
The No Surprises Act good-faith-estimate requirement applies to all licensed providers offering services to self-pay or uninsured patients — not just hospitals or large groups. The estimate must be provided within timeframes that vary by how far in advance the appointment is scheduled.
Patient-provider dispute resolution under NSA typically defaults to the patient when the practice cannot produce a timely good-faith estimate. The penalty is the full disputed amount being struck.
Covered entities must annually recertify their 340B eligibility through HRSA. Missing the recertification window pushes the entity to inactive status, which means immediate loss of 340B pricing and potentially diversion violations on previously dispensed drugs. Reinstatement requires a new application.
The discount value of 340B pricing for a covered entity often exceeds six figures annually. Letting the recertification lapse for paperwork reasons is one of the most expensive administrative errors in the regulation.
Get Indiana healthcare intelligence delivered to your inbox every morning.
Subscribe FreeView all past issues
Feature your brand across the U.S., Canada, and select international markets and 10 industry verticals.
Become a National Partner